AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 10, 2006
Issued Date -
N/A
app pub date -
Sep 30, 2003
filing date -
Sep 30, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
AT.sub.4 receptor agonists are potent activators of angiogenesis and can be used to treat diseases that are characterized by vascular insufficiency. AT.sub.4 receptor antagonists, which are potent inhibitors of angiogenesis, and can be used as anti-angiogenic agents for the treatment of cancer, diabetic retinopathy, rheumatoid arthritis, psoriasis, atherosclerotic plaque formation, and any disease process that is characterized by excessive, undesired or inappropriate angiogenesis or proliferation of endothelial cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully